(VIANEWS) – Ligand Pharmaceuticals Incorporated (LGND), CubeSmart (CUBE), Quanta Services (PWR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Ligand Pharmaceuticals Incorporated (LGND)
49.9% sales growth and 5.85% return on equity
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19; Teriparatide injection product for osteoporosis; Vaxneuvance for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes; and Pneumosil, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia among children. The company also offers Rylaze, a recombinant erwinia asparaginase for the treatment of acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; Nexterone, a captisol-enabled formulation of amiodarone; and Zulresso, a captisol-enabled formulation of brexanolone for the treatment of postpartum depression. In addition, it provides Noxafil-IV, a captisol-enabled formulation of posaconazole for IV use; Duavee for the treatment of post-menopausal symptoms in women; Exemptia for autoimmune diseases; Vivitra for breast cancer; and Bryxta and Zybev for various indications. The company has alliances, licenses, and other business relationships with Amgen, Merck, Pfizer, Jazz, Takeda, Gilead Sciences, and Baxter International. Further, it sells Captisol materials. Ligand Pharmaceuticals Incorporated was incorporated in 1987 and is based in San Diego, California.
Earnings Per Share
As for profitability, Ligand Pharmaceuticals Incorporated has a trailing twelve months EPS of $2.33.
PE Ratio
Ligand Pharmaceuticals Incorporated has a trailing twelve months price to earnings ratio of 45.07. Meaning, the purchaser of the share is investing $45.07 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.85%.
2. CubeSmart (CUBE)
14.8% sales growth and 14.15% return on equity
CubeSmart is a self-administered and self-managed real estate investment trust. The Company's self-storage properties are designed to offer affordable, easily accessible and secure storage space for residential and commercial customers. According to the 2020 Self-Storage Almanac, CubeSmart is one of the top three owners and operators of self-storage properties in the United States.
Earnings Per Share
As for profitability, CubeSmart has a trailing twelve months EPS of $1.78.
PE Ratio
CubeSmart has a trailing twelve months price to earnings ratio of 29.9. Meaning, the purchaser of the share is investing $29.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.15%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Oct 1, 2024, the estimated forward annual dividend rate is 2.04 and the estimated forward annual dividend yield is 3.83%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 1.9%, now sitting on 1.06B for the twelve trailing months.
3. Quanta Services (PWR)
14.1% sales growth and 13.08% return on equity
Quanta Services, Inc. provides infrastructure solutions for the electric and gas utility, renewable energy, communications, and pipeline and energy industries in the United States, Canada, Australia, and internationally. The company's Electric Power Infrastructure Solutions segment engages in the design, procurement, construction, upgrade, repair, and maintenance of electric power transmission and distribution infrastructure and substation facilities; installation, maintenance, and upgrade of electric power infrastructure projects; installation of smart grid technologies on electric power networks; and design, installation, maintenance, and repair of commercial and industrial wirings. This segment also offers aviation services; emergency restoration services; and other engineering and technical services; design and construction solutions to wireline and wireless communications, cable multi-system operators, and other customers; and training for electric workers, as well as training for the gas distribution and communications industries. The company's Renewable Energy Infrastructure Solutions segment is involved in engineering, procurement, construction, repair, and maintenance of wind, solar, and hydropower generation facilities, as well as battery storage facilities; and provision of engineering and construction services for substations and switchyards, transmission, and other electrical infrastructures. The company's Underground Utility and Infrastructure Solutions segment offers design, engineering, procurement, construction, upgrade, repair, and maintenance services for natural gas systems for gas utility customers; fabrication services for pipeline support systems and structures and facilities; and engineering and construction services for pipeline and storage systems, and compressor and pump stations. The company was formerly known as Fabal Construction, Inc. and changed its name to Quanta Services, Inc. in November 1997. The company was incorporated in 1997 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Quanta Services has a trailing twelve months EPS of $5.31.
PE Ratio
Quanta Services has a trailing twelve months price to earnings ratio of 50.76. Meaning, the purchaser of the share is investing $50.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.08%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 22.3% and 26%, respectively.
Yearly Top and Bottom Value
Quanta Services’s stock is valued at $269.54 at 11:22 EST, under its 52-week high of $286.87 and way above its 52-week low of $153.74.
Sales Growth
Quanta Services’s sales growth is 17.5% for the current quarter and 14.1% for the next.
Volume
Today’s last reported volume for Quanta Services is 475559 which is 47.57% below its average volume of 907143.
4. Option Care Health (OPCH)
10.5% sales growth and 14.64% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.2.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 25.97. Meaning, the purchaser of the share is investing $25.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.64%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14.8%, now sitting on 4.59B for the twelve trailing months.
Moving Average
Option Care Health’s value is below its 50-day moving average of $31.22 and above its 200-day moving average of $31.05.
Volume
Today’s last reported volume for Option Care Health is 1094170 which is 31.43% below its average volume of 1595840.
Yearly Top and Bottom Value
Option Care Health’s stock is valued at $31.17 at 11:22 EST, below its 52-week high of $34.63 and way above its 52-week low of $26.11.
